BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT. – Trademark Portfolio

Entity Type: 03

BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include AVEMAR. The owner is based in KUNFEHERTO, 6413.

IV. KORZET 6

KUNFEHERTO, 6413 , HU

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AVEMAR
AVEMAR
Cancelled 2012
AVEMAR
AVEMAR
Registered 1998

Trademark Classifications

BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT. have?

BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT. file in?

BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT.'s most well-known trademarks?

BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT.'s registered trademark portfolio includes well-known marks such as AVEMAR. These are among 1 currently registered trademark in the portfolio.

What is BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT.'s trademark registration success rate?

BIROPHARMA ELSO MAGYAR BIOTECHNOLOGIAI KFT. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.